SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
17317398
Source:
http://linkedlifedata.com/resource/pubmed/id/17317398
Search
Subject
(
49
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0271084
,
umls-concept:C0796392
,
umls-concept:C1135130
,
umls-concept:C1517572
,
umls-concept:C1656863
,
umls-concept:C2603343
pubmed:issue
3
pubmed:dateCreated
2007-2-23
pubmed:abstractText
To report the short-term study of intravitreal bevacizumab (Avastin) in the treatment of neovascular age-related macular degeneration (AMD).
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/0370500
pubmed:citationSubset
AIM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Angiogenesis Inhibitors
,
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal
,
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, Humanized
,
http://linkedlifedata.com/resource/pubmed/chemical/VEGFA protein, human
,
http://linkedlifedata.com/resource/pubmed/chemical/Vascular Endothelial Growth Factor A
,
http://linkedlifedata.com/resource/pubmed/chemical/bevacizumab
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0002-9394
pubmed:author
pubmed-author:ChenChristine YCY
,
pubmed-author:HeriotWilson JWJ
,
pubmed-author:WongTien YTY
pubmed:issnType
Print
pubmed:volume
143
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
510-2
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:17317398-Aged
,
pubmed-meshheading:17317398-Angiogenesis Inhibitors
,
pubmed-meshheading:17317398-Antibodies, Monoclonal
,
pubmed-meshheading:17317398-Antibodies, Monoclonal, Humanized
,
pubmed-meshheading:17317398-Choroidal Neovascularization
,
pubmed-meshheading:17317398-Female
,
pubmed-meshheading:17317398-Humans
,
pubmed-meshheading:17317398-Injections
,
pubmed-meshheading:17317398-Macular Degeneration
,
pubmed-meshheading:17317398-Male
,
pubmed-meshheading:17317398-Tomography, Optical Coherence
,
pubmed-meshheading:17317398-Vascular Endothelial Growth Factor A
,
pubmed-meshheading:17317398-Visual Acuity
,
pubmed-meshheading:17317398-Vitreous Body
pubmed:year
2007
pubmed:articleTitle
Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration: a short-term study.
pubmed:affiliation
Center for Eye Research Australia, University of Melbourne, Melbourne, Victoria, Australia.
pubmed:publicationType
Journal Article